Legalization of Medical Marijuana in Indonesia from the Human Rights Perspectives: Lessons Learned from Three ASEAN Countries
Main Article Content
Abstract
Marijuana (cannabis) as a therapeutic medication has been used and recognized as part of the health system in several countries. In contrast, marijuana in Indonesia is classified as a class I narcotic under Law Number 35 of 2009 on Narcotics, which is prohibited and cannot be used as medication. However, a detailed examination of the Narcotics Act reveals some loopholes and ambiguities that could be exploited to legalize marijuana as a medication to cure certain illnesses. The present study employs normative legal research, specifically a statutory approach, to justify using marijuana for medical purposes. In addition, a legal comparative method is also used in this study to analyze the use of medical marijuana in three ASEAN countries: Thailand, Malaysia, and Singapore. Despite having a reputation for having highly stringent regulations on narcotics, Indonesia can benefit from the experiences of other ASEAN nations, such as Singapore and Malaysia, who have legalized medical marijuana. This consideration is prompted by the fact that certain individuals have shared positive outcomes from using ‘illegal’ medical marijuana as a form of health treatment. However, it is disheartening to note that these individuals have also had to witness the unfortunate loss of their loved ones and, in some cases, face legal consequences such as imprisonment. Conducting comprehensive research on the use of medicinal marijuana in Indonesia is crucial to upholding the citizens' right to health, as the right to health is a significant component of human rights.
Article Details
How to Cite
Yustina, E. W., Simandjuntak, M. E., Nasser, M., Blum, J. D., & Trajera, S. M. (2023). Legalization of Medical Marijuana in Indonesia from the Human Rights Perspectives: Lessons Learned from Three ASEAN Countries. Lex Scientia Law Review, 7(2), 569-628. https://doi.org/10.15294/lesrev.v7i2.77670
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
All writings published in this journal are personal views of the authors and do not represent the view of this journal and the author's affiliated institutions. Authors retain the copyrights under this license, see our copyrights notice.
References
A Singapore Government Agency. “The Singapore Government’s Position on the Recommendations of the World Health Organisation Expert Committee on Drug Dependence, on Cannabis and Cannabis-Related Substances, Voted on at the Reconvened 63rd Session of the Commission on Narcotic Drugs.” Media Room. Singapore: A Singapore Government Agency Website, 2020. https://www.mha.gov.sg/mediaroom/press-releases/the-singapore-government-s-position-on-the-recommendations-of-the-world-health-organisation-expert-committee-on-drug-dependence-on-cannabis-and-cannabis-related-substances-voted-on-at-the-reconvened-63rd-ses.
Aggarwal, Sunil K., Gregory T. Carter, Mark D. Sullivan, Craig ZumBrunnen, Richard Morrill, and Jonathan D. Mayer. “Medicinal Use of Cannabis in the United States: Historical Perspectives, Current Trends, and Future Directions.” Journal of Opioid Management 5, no. 3 (2009): 153–68. https://doi.org/10.5055/jom.2009.0016.
Angerah, Pijar. “Ganja Medis: Perjuangan Santi Warastuti Demi Mencari Pengobatan Untuk Anaknya.” BBC News Indonesia, 2022. https://www.bbc.com/indonesia/indonesia-61956811.
Antolak-Saper, Natalia, Sara Kowal, Samira Lindsey, Ngeow Chow, and Ying Thaatchaayini Kananatu. Drug Offences and the Death Penalty in Malaysia: Fair Trial Rights and Ramifications. (Victoria: Monash University, 2020).
Arbar, Thea Fathanah. “Malaysia Izinkan Penggunaan Ganja Untuk Medis, Ini Syaratnya!” CNBC Indonesia, 2021. https://www.cnbcindonesia.com/news/20211114073413-4-291341/malaysia-izinkan-penggunaan-ganja-untuk-medis-ini-syaratnya.
Aripin, Zaenal. “Warga Singapura Setuju Ganja Legal Untuk Medis.” RBG.id, 2022. https://www.rbg.id/internasional/pr-9446587600/warga-singapura-setuju-ganja-legal-untuk-medis.
Aroonsrimorakot, Sayam, Meena Laiphrakpam, and Orapun Metadilogkul. “Social, Religious, Recreational and Medicinal Usage of Cannabis in India and Thailand.” Journal of Thai Interdisciplinary Research 14, no. 4 (2019): 43–50.
Asmoro, Widi, and Palupi Lindiasari Samputra. “Analisis Naratif Kebijakan: Kebijakan Ganja Medis Di Indonesia.” Matra Pembaruan 5, no. 1 (2021): 13–24. https://doi.org/10.21787/mp.5.1.2021.13-24.
Ayunda, Vina Rahmi. “Peluang dan Tantangan Legalisasi Penggunaan Ganja Untuk Kepentıngan Medis di Indonesıa Ditınjau Dari Perspektif UU Kesehatan.” Proceedings Conference on Management, Business, Innovation, Education and Social Science 1 (2021): 331–340. https://journal.uib.ac.id/index.php/combines/article/view/4457/1174
Badowski, Melissa E., and Paa Kwesi Yanful. “Dronabinol Oral Solution in the Management of Anorexia and Weight Loss in AIDS and Cancer.” Therapeutics and Clinical Risk Management 14 (2018): 643–51. https://doi.org/10.2147/TCRM.S126849.
Bahji, Anees, and Callum Stephenson. “International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis.” International Journal of Environmental Research and Public Health 16, no. 17 (2019). https://doi.org/10.3390/ijerph16173095.
Bandawe, Gama. “Medical Cannabis and Cannabidiol: A New Harvest for Malawi.” Malawi Medical Journal 34, no. 2 (2022): 138–42. https://doi.org/10.4314/mmj.v34i2.10.
BBC News Indonesia. “PNS Penanam Ganja Untuk Obat Istri Divonis Delapan Bulan Penjara,” 2017. https://www.bbc.com/indonesia/indonesia-40799686.
Bifulco, Maurizio, and Simona Pisanti. “Medicinal Use of Cannabis in Europe.” EMBO Reports 16 (2015). https://doi.org/10.15252/embr.201439742.
Boggs, Douglas L., Jacques D. Nguyen, Daralyn Morgenson, Michael A. Taffe, and Mohini Ranganathan. “Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Î " 9-Tetrahydrocannabinol.” Neuropsychopharmacology 43, no. 1 (2018): 142–54. https://doi.org/10.1038/npp.2017.209.
Bridgeman, Mary Barna, and Daniel T. Abazia. “Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.” Pharmacy and Therapeutics 42, no. 3 (2017): 180–88. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/pdf/ptj4203180.pdf.
Central Narcotics Bureau. “Know Cannabis: An Information Booklet on the Harmful Effects of Cannabis.” Singapore: Central Narcotics Bureau, 2020. https://www.cnb.gov.sg/docs/default-source/educational-resources-documents/know-cannabis_booklet.pdf.
“CESCR General Comment No. 14: The Right to the Highest Attainable Standard of Health (Art. 12).” Adopted at the Twenty-Second Session of the Committee on Economic, Social and Cultural Rights, on 11 August 2000 (Contained in Document E/C.12/2000/4). Vol. 2000, 2000. https://www.ohchr.org/Documents/Issues/Women/WRGS/Health/GC14.pdf.
Chia, Doris Xin Yi, Charis Wei Ling Ng, Pezhummoottil Vasudevan Nair Asharani, Sabina Au Yong, Jun Wen Tan, Noor Azizah Bte Zainuldin, Samuel Kee Guan Chua, Lambert Tchern Kuang Low, Christopher Cheng Soon Cheok, and Gomathinayagam Kandasami. “Understanding Cannabis Use in Singapore: Profile of Users and Drug Progression.” Singapore Medical Journal 64, no. 6 (2023): 385–90. https://doi.org/10.11622/smedj.2022071.
CNN Indonesia. “Malaysia Izinkan Impor Dan Gunakan Ganja Untuk Medis.” CNN Indonesia, 2021. https://www.cnnindonesia.com/internasional/20211115193632-106-721563/malaysia-izinkan-impor-dan-gunakan-ganja-untuk-medis.
Colebatch, HK. “The Idea of Policy Design: Intention, Process, Outcome, Meaning and Validity.” Public Policy and Administration 33, no. 4 (2018): 365–83. https://doi.org/10.1177/0952076717709525.
Dapari, Rahmat, Mohd Hafizuddin Mahfot, Ahmad Iqmer Nashriq Mohd Nazan, Mohd Rohaizat Hassan, Nazri Che Dom, and Syed Sharizman Syed Abdul Rahim. “Acceptance towards Decriminalization of Medical Marijuana among Adults in Selangor, Malaysia.” PLoS ONE 17, no. 2 February (2022): 1–17. https://doi.org/10.1371/journal.pone.0262819.
European Medicines Agency. Public Summary of Opinion on Orphan Designation: Cannabidiol for the treatment of Lennox-Gastaut Syndrome (London, UK: European Medicines Agency, 2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. (Luxembourg: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2018). https://doi.org/10.2810/979004.
Farisa, Fitria Chusna. “Ganja Fidelis Untuk Istrinya: Kisah Ganja Medis Fidelis Untuk Sang Istri Yang Berujung Bui.” KOMPAS, 2022. https://amp.kompas.com/nasional/read/2022/06/29/13511341/kisah-ganja-medis-fidelis-untuk-sang-istri-yang-berujung-bui.
Felberbaum, Michael. “FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy.” Online FDA Release (2018). https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms.
Gaffurie, Ganal Valian. “Perbandingan Kebijakan Indonesia & Thailand Tentang Ganja Dari Perspektif Kepentingan Nasional: Kebijakan Pemerintah Thailand Dan Indonesia Tentang Narkotika Jenis Ganja.” Badan Narkotika Nasional Provinsi Daerah Istimewa Yogyakarta, 2022. https://yogyakarta.bnn.go.id/perbandingan-kebijakan-indonesia-thailand-tentang-ganja-dari/.
Greco, Rosaria, Miriam Francavilla, Chiara Demartini, Anna Maria Zanaboni, Mikael H. Sodergren, Sara Facchetti, Barbara Pacchetti, Michela Palmisan, Valentina Franco, and Cristina Tassorelli. “Characterization of the Biochemical and Behavioral Effects of Cannabidiol: Implications for Migraine.” Journal of Headache and Pain 24, no. 1 (2023): 1–15. https://doi.org/10.1186/s10194-023-01589-y.
Harring, Sidney. “Death , Drugs and Development : Malaysia ’ s Mandatory Death Penalty for Traffickers and the International War on Drugs.” Columbia Journal of Transnational Law 29 (1991): 365–405.
Harry, Lucy. “Rethinking the Relationship between Women, Crime and Economic Factors: The Case-Study of Women Sentenced to Death for Drug Trafficking in Malaysia.” Laws 10, no. 9 (2021). https://doi.org/10.3390/laws10010009.
Isa. “Aturan Legalisasi Ganja Di Thailand Yang Akan Berlaku Kamis Besok.” CNN Indonesia, 2022. https://www.cnnindonesia.com/internasional/20220608112636-106-806289/aturan-legalisasi-ganja-di-thailand-yang-akan-berlaku-kamis-besok.
Isriawaty, Fheriyal. “Tanggung Jawab Negara Dalam Pemenuhan Hak Atas Kesehatan Masyarakat Berdasarkan Undang Undang Dasar Negara Republik Indonesia.” Jurnal Ilmu Hukum Legal Opinion 3, no. 2 (2015): 1–10.
Kama, I Putu Satya, Anak Agung Ayu Intan Prameswari, and Sukma Sushanti. “Kepentingan Thailand Dalam Penerapan Kebijakan Legalisasi Ganja.” Dikshi 1, no. 1 (2021): 1–15. https://ojs.unud.ac.id/index.php/hi/article/view/70049.
Kanato, Manop, Chuanpit Choomwattana, Rachanikorn Sarasiri, and Poonrut Leyatikul. Drug Monitoring Report 2019. (Bangkok, ASEAN Narcotics Cooperation Center, 2020). Available online at https://asean.org/wp-content/uploads/ADM-Report-2019.pdf.
Kinney, Eleanor D. “The International Human Right to Health: What Does This Mean for Our Nation and World?” Indiana Law Review 693, no. December (2004). https://mckinneylaw.iu.edu/ilr/pdf/vol34p1457.pdf.
Krcevski-Skvarc, N., C. Wells, and W. Häuser. “Availability and Approval of Cannabis-Based Medicines for Chronic Pain Management and Palliative/Supportive Care in Europe: A Survey of the Status in the Chapters of the European Pain Federation.” European Journal of Pain (United Kingdom) 22, no. 3 (2018): 440–54. https://doi.org/10.1002/ejp.1147.
Kuret, Tadeja, Mateja Erdani Kreft, Rok Romih, and Peter Veranič. “Cannabidiol as a Promising Therapeutic Option in IC/BPS: In Vitro Evaluation of Its Protective Effects against Inflammation and Oxidative Stress.” International Journal of Molecular Sciences 24, no. 5 (2023). https://doi.org/10.3390/ijms24055055.
Lee, Jimmy, Christopher Cheok, Gomathinayagam Kandasami, Attilio Rapisarda, and Ho New Fei. “A Literature Review on Medical Cannabis.” Singapore, 2015. https://www.mha.gov.sg/docs/default-source/media-room-doc/a-literature-review-on-medical-cannabis.pdf.
Malik, Syamsul, Luriana Manalu, and Rika Juniarti. “Legalisasi Ganja Dalam Sektor Medis Perspektif Hukum.” Jurnal Rechten : Riset Hukum Dan Hak Asasi Manusia 2, no. 2 (2022): 1–9. https://doi.org/10.52005/rechten.v2i2.52.
Marisca Evalina Gondokesumo, and Nabbilah Amir. “Legality of Marijuana Use in the Need for Medical Treatment in Indonesia (Judging From Law Number 36 of 2009 Concerning Health and Law Number 35 of 2009 Concerning Narcotics).” Journal Equity of Law and Governance 1, no. 2 (2021): 119–26. https://doi.org/10.55637/elg.1.2.3938.119-126.
Mead, Alice. “Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.” Frontiers in Plant Science 10, no. June (2019): 1–10. https://doi.org/10.3389/fpls.2019.00697.
Monalisa, Monalisa, Sri Rahayu, and Dheny Wahyudhi. “A Comparative Study on Criminal Sanction Against Drugs Offenders.” Jambe Law Journal 2, no. 2 (2020): 181–206. https://doi.org/10.22437/jlj.2.2.181-206.
MTP Connect & Deloitte Access Economics. “Australian Medicinal Cannabis Industry Report.” Victoria, Australia, 2021. https://www.mtpconnect.org.au/images/MTPC_Australian Medicinal Cannabis Industry.pdf.
National Center for Biotechnology Information. PubChem Compound Summary for CID 16078, Dronabinol (Maryland, US: National Center for Biotechnology Information, 2023). https://pubchem.ncbi.nlm.nih.gov/compound/Dronabinol.
Nik Mohamed, Mohamad Haniki, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek, and Norny Syafinaz Ab Rahman. “Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements.” Journal of the Malaysian Parliament 2 (2022): 248–73. https://doi.org/10.54313/journalmp.v2i.66.
Nur Arfiani, and Indah Woro Utami. “Penggunaan Ganja Medis Dalam Pengobatan Rasional Dan Pengaturannya Di Indonesia.” Jurnal Hukum Dan Etika Kesehatan 2 (2022): 56–68. https://doi.org/10.30649/jhek.v2i1.45.
Perucca, Emilio. “Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?” Journal of Epilepsy Research 7, no. 2 (2017): 61–76. https://doi.org/10.14581/jer.17012.
Pitri Susanti, Ni. “Identifikasi Kandungan Cannabinoid dalam Ekstrak Batang Ganja Dengan Metode AL-TLC dan HPTLC Spectrophotodensitometry.” Indonesian Journal of Legal and Forensic Sciences 2, no. 1 (2012): 282193.
Pramana, Edy. “Lebih Dari Separo Warga Singapura Setuju Gunakan Ganja Untuk Medis.” JawaPos.com, 2022. https://www.jawapos.com/internasional/01411411/lebih-dari-separo-warga-singapura-setuju-gunakan-ganja-untuk-medis.
Prassetyo, Erik Dwi. “Legalisasi Ganja Medis (Analisis Putusan MK Nomor 106/PUU-XVIII/2020).” Jurnal Analisis Hukum 5, no. 2 (2022): 147–62. https://doi.org/10.38043/jah.v5i2.3735.
Pratama, Akbar Yudha, Ufran Ufran, and Lalu Saepuddin. “Studi Komparasi Antara Indonesia Dengan Thailand Terkait Kebijakan Legislasi Ganja.” Parhesia 1, no. 1 (2023): 70–81. https://journal.unram.ac.id/index.php/Parhesia/article/view/2578/1324.
Irianto, Agus, et.al. Survei Penyalahgunaan Narkoba Tahun 2021. (Jakarta: Pusat Penelitian, Data, dan Informasi Badan Narkotika Nasional Republik Indonesia, 2022). Available online at < https://ppid.bnn.go.id/konten/unggahan/2020/10/SURVEI-NASIONAL-PENYALAHGUNAAN-NARKOBA-TAHUN-2021.pdf>
Qadrina, Nurlaelatil, and M. Chaerul Risal. “Legalisasi Ganja Sebagai Tanaman Obat: Perlukah?” Jurnal Al Tasyri’Iyyah 2, no. 1 (2022): 48–58. https://doi.org/10.24252/jat.vi.30201.
Setiawan, Riyan. “Uji Materi UU Narkotika: Perjuangan Seorang Ibu Menuntut Legalisasi Ganja Medis Demi Anaknya.” Tirto.id, 2022. https://tirto.id/perjuangan-seorang-ibu-menuntut-legalisasi-ganja-medis-demi-anaknya-gtsY.
Souza, Maíra Ribeiro de, Amélia Teresinha Henriques, and Renata Pereira Limberger. “Medical Cannabis Regulation: An Overview of Models around the World with Emphasis on the Brazilian Scenario.” Journal of Cannabis Research 4, no. 1 (2022). https://doi.org/10.1186/s42238-022-00142-z.
Stockings, Emily, Dino Zagic, Gabrielle Campbell, Megan Weier, Wayne D. Hall, Suzanne Nielsen, Geoffrey K. Herkes, Michael Farrell, and Louisa Degenhardt. “Evidence for Cannabis and Cannabinoids for Epilepsy: A Systematic Review of Controlled and Observational Evidence.” Journal of Neurology, Neurosurgery and Psychiatry 89, no. 7 (2018): 741–53. https://doi.org/10.1136/jnnp-2017-317168.
Subramaniam, Chandra Segaran. “Drug Laws in Malaysia: Whether the Drug Laws Have Been Effective in Curbing the Drug Menace in Malaysia.” Resource Material Series No. 106, 2018. https://www.unafei.or.jp/publications/pdf/RS_No106/No106_10_IP_Malaysia.pdf.
The European Parliament. “Use of Cannabis for Medicinal Purposes,” no. February 2019 (2020): 115–18.
Undang-Undang Nomor 39 Tahun 1999 tentang Hak Asasi Manusia, Pub. L. No. 39 (1999). https://www.dpr.go.id/dokjdih/document/uu/440.pdf.
Undang-Undang Republik Indonesia Nomor 17 Tahun 2023 Tentang Kesehatan, Undang-Undang § (2023). https://www.kemkes.go.id/id/undang-undang-republik-indonesia-nomor-17-tahun-2023-tentang-kesehatan.
UNODC. "Herbal Cannabis for Medical Use: A Spectrum of Regulatory Approaches". Word Drug Report 2023 (2023). https://doi.org/10.18356/9789210028233c024.
Victor, Brenda, Kathy Hager, and Shannon Stacy. “Re-Legalizing Cannabis for Medical Use in the USA.” Journal of Public Health (United Kingdom) 44, no. 3 (2022): 679–84. https://doi.org/10.1093/pubmed/fdab066.
WHO. “WHO Endorses Decisions of Expert Committee on Cannabis and Other Substances.” WHO News Online (2019). https://www.who.int/news/item/03-04-2019-WHO-endorses-decisions-Expert-Committee-on-cannabis-and-other-substances.
WHO. “WHO Expert Committee on Drug Dependence Meets to Review Cannabis and Other Substances.” World Health Organization, 2018. https://www.who.int/news/item/16-11-2018-Expert-Committee-on-Drug-Dependence-meets-to-review-cannabis-and-other-substances.
Yamin, Alicia Ely. “The Right to Health under International Law and Its Relevance to the United States.” American Journal of Public Health 95, no. 7 (2005): 1156–61. https://doi.org/10.2105/AJPH.2004.055111.
Zinboonyahgoon, Nantthasorn, Sahaphume Srisuma, Wirun Limsawart, Andrew S.C. Rice, and Chuthamanee Suthisisang. “Medicinal Cannabis in Thailand: 1-Year Experience after Legalization.” Pain 162, no. 7 (2021): S105–9. https://doi.org/10.1097/j.pain.0000000000001936.
Zulfikri, Agung, and Ujang Badru Jaman. “Urgensi Legalitas Ganja Untuk Kepentingan Medis.” Jurnal Hukum dan HAM West Science 01, no. 1 (2022): 8–14.
Aggarwal, Sunil K., Gregory T. Carter, Mark D. Sullivan, Craig ZumBrunnen, Richard Morrill, and Jonathan D. Mayer. “Medicinal Use of Cannabis in the United States: Historical Perspectives, Current Trends, and Future Directions.” Journal of Opioid Management 5, no. 3 (2009): 153–68. https://doi.org/10.5055/jom.2009.0016.
Angerah, Pijar. “Ganja Medis: Perjuangan Santi Warastuti Demi Mencari Pengobatan Untuk Anaknya.” BBC News Indonesia, 2022. https://www.bbc.com/indonesia/indonesia-61956811.
Antolak-Saper, Natalia, Sara Kowal, Samira Lindsey, Ngeow Chow, and Ying Thaatchaayini Kananatu. Drug Offences and the Death Penalty in Malaysia: Fair Trial Rights and Ramifications. (Victoria: Monash University, 2020).
Arbar, Thea Fathanah. “Malaysia Izinkan Penggunaan Ganja Untuk Medis, Ini Syaratnya!” CNBC Indonesia, 2021. https://www.cnbcindonesia.com/news/20211114073413-4-291341/malaysia-izinkan-penggunaan-ganja-untuk-medis-ini-syaratnya.
Aripin, Zaenal. “Warga Singapura Setuju Ganja Legal Untuk Medis.” RBG.id, 2022. https://www.rbg.id/internasional/pr-9446587600/warga-singapura-setuju-ganja-legal-untuk-medis.
Aroonsrimorakot, Sayam, Meena Laiphrakpam, and Orapun Metadilogkul. “Social, Religious, Recreational and Medicinal Usage of Cannabis in India and Thailand.” Journal of Thai Interdisciplinary Research 14, no. 4 (2019): 43–50.
Asmoro, Widi, and Palupi Lindiasari Samputra. “Analisis Naratif Kebijakan: Kebijakan Ganja Medis Di Indonesia.” Matra Pembaruan 5, no. 1 (2021): 13–24. https://doi.org/10.21787/mp.5.1.2021.13-24.
Ayunda, Vina Rahmi. “Peluang dan Tantangan Legalisasi Penggunaan Ganja Untuk Kepentıngan Medis di Indonesıa Ditınjau Dari Perspektif UU Kesehatan.” Proceedings Conference on Management, Business, Innovation, Education and Social Science 1 (2021): 331–340. https://journal.uib.ac.id/index.php/combines/article/view/4457/1174
Badowski, Melissa E., and Paa Kwesi Yanful. “Dronabinol Oral Solution in the Management of Anorexia and Weight Loss in AIDS and Cancer.” Therapeutics and Clinical Risk Management 14 (2018): 643–51. https://doi.org/10.2147/TCRM.S126849.
Bahji, Anees, and Callum Stephenson. “International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis.” International Journal of Environmental Research and Public Health 16, no. 17 (2019). https://doi.org/10.3390/ijerph16173095.
Bandawe, Gama. “Medical Cannabis and Cannabidiol: A New Harvest for Malawi.” Malawi Medical Journal 34, no. 2 (2022): 138–42. https://doi.org/10.4314/mmj.v34i2.10.
BBC News Indonesia. “PNS Penanam Ganja Untuk Obat Istri Divonis Delapan Bulan Penjara,” 2017. https://www.bbc.com/indonesia/indonesia-40799686.
Bifulco, Maurizio, and Simona Pisanti. “Medicinal Use of Cannabis in Europe.” EMBO Reports 16 (2015). https://doi.org/10.15252/embr.201439742.
Boggs, Douglas L., Jacques D. Nguyen, Daralyn Morgenson, Michael A. Taffe, and Mohini Ranganathan. “Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Î " 9-Tetrahydrocannabinol.” Neuropsychopharmacology 43, no. 1 (2018): 142–54. https://doi.org/10.1038/npp.2017.209.
Bridgeman, Mary Barna, and Daniel T. Abazia. “Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.” Pharmacy and Therapeutics 42, no. 3 (2017): 180–88. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/pdf/ptj4203180.pdf.
Central Narcotics Bureau. “Know Cannabis: An Information Booklet on the Harmful Effects of Cannabis.” Singapore: Central Narcotics Bureau, 2020. https://www.cnb.gov.sg/docs/default-source/educational-resources-documents/know-cannabis_booklet.pdf.
“CESCR General Comment No. 14: The Right to the Highest Attainable Standard of Health (Art. 12).” Adopted at the Twenty-Second Session of the Committee on Economic, Social and Cultural Rights, on 11 August 2000 (Contained in Document E/C.12/2000/4). Vol. 2000, 2000. https://www.ohchr.org/Documents/Issues/Women/WRGS/Health/GC14.pdf.
Chia, Doris Xin Yi, Charis Wei Ling Ng, Pezhummoottil Vasudevan Nair Asharani, Sabina Au Yong, Jun Wen Tan, Noor Azizah Bte Zainuldin, Samuel Kee Guan Chua, Lambert Tchern Kuang Low, Christopher Cheng Soon Cheok, and Gomathinayagam Kandasami. “Understanding Cannabis Use in Singapore: Profile of Users and Drug Progression.” Singapore Medical Journal 64, no. 6 (2023): 385–90. https://doi.org/10.11622/smedj.2022071.
CNN Indonesia. “Malaysia Izinkan Impor Dan Gunakan Ganja Untuk Medis.” CNN Indonesia, 2021. https://www.cnnindonesia.com/internasional/20211115193632-106-721563/malaysia-izinkan-impor-dan-gunakan-ganja-untuk-medis.
Colebatch, HK. “The Idea of Policy Design: Intention, Process, Outcome, Meaning and Validity.” Public Policy and Administration 33, no. 4 (2018): 365–83. https://doi.org/10.1177/0952076717709525.
Dapari, Rahmat, Mohd Hafizuddin Mahfot, Ahmad Iqmer Nashriq Mohd Nazan, Mohd Rohaizat Hassan, Nazri Che Dom, and Syed Sharizman Syed Abdul Rahim. “Acceptance towards Decriminalization of Medical Marijuana among Adults in Selangor, Malaysia.” PLoS ONE 17, no. 2 February (2022): 1–17. https://doi.org/10.1371/journal.pone.0262819.
European Medicines Agency. Public Summary of Opinion on Orphan Designation: Cannabidiol for the treatment of Lennox-Gastaut Syndrome (London, UK: European Medicines Agency, 2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. (Luxembourg: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2018). https://doi.org/10.2810/979004.
Farisa, Fitria Chusna. “Ganja Fidelis Untuk Istrinya: Kisah Ganja Medis Fidelis Untuk Sang Istri Yang Berujung Bui.” KOMPAS, 2022. https://amp.kompas.com/nasional/read/2022/06/29/13511341/kisah-ganja-medis-fidelis-untuk-sang-istri-yang-berujung-bui.
Felberbaum, Michael. “FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy.” Online FDA Release (2018). https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms.
Gaffurie, Ganal Valian. “Perbandingan Kebijakan Indonesia & Thailand Tentang Ganja Dari Perspektif Kepentingan Nasional: Kebijakan Pemerintah Thailand Dan Indonesia Tentang Narkotika Jenis Ganja.” Badan Narkotika Nasional Provinsi Daerah Istimewa Yogyakarta, 2022. https://yogyakarta.bnn.go.id/perbandingan-kebijakan-indonesia-thailand-tentang-ganja-dari/.
Greco, Rosaria, Miriam Francavilla, Chiara Demartini, Anna Maria Zanaboni, Mikael H. Sodergren, Sara Facchetti, Barbara Pacchetti, Michela Palmisan, Valentina Franco, and Cristina Tassorelli. “Characterization of the Biochemical and Behavioral Effects of Cannabidiol: Implications for Migraine.” Journal of Headache and Pain 24, no. 1 (2023): 1–15. https://doi.org/10.1186/s10194-023-01589-y.
Harring, Sidney. “Death , Drugs and Development : Malaysia ’ s Mandatory Death Penalty for Traffickers and the International War on Drugs.” Columbia Journal of Transnational Law 29 (1991): 365–405.
Harry, Lucy. “Rethinking the Relationship between Women, Crime and Economic Factors: The Case-Study of Women Sentenced to Death for Drug Trafficking in Malaysia.” Laws 10, no. 9 (2021). https://doi.org/10.3390/laws10010009.
Isa. “Aturan Legalisasi Ganja Di Thailand Yang Akan Berlaku Kamis Besok.” CNN Indonesia, 2022. https://www.cnnindonesia.com/internasional/20220608112636-106-806289/aturan-legalisasi-ganja-di-thailand-yang-akan-berlaku-kamis-besok.
Isriawaty, Fheriyal. “Tanggung Jawab Negara Dalam Pemenuhan Hak Atas Kesehatan Masyarakat Berdasarkan Undang Undang Dasar Negara Republik Indonesia.” Jurnal Ilmu Hukum Legal Opinion 3, no. 2 (2015): 1–10.
Kama, I Putu Satya, Anak Agung Ayu Intan Prameswari, and Sukma Sushanti. “Kepentingan Thailand Dalam Penerapan Kebijakan Legalisasi Ganja.” Dikshi 1, no. 1 (2021): 1–15. https://ojs.unud.ac.id/index.php/hi/article/view/70049.
Kanato, Manop, Chuanpit Choomwattana, Rachanikorn Sarasiri, and Poonrut Leyatikul. Drug Monitoring Report 2019. (Bangkok, ASEAN Narcotics Cooperation Center, 2020). Available online at https://asean.org/wp-content/uploads/ADM-Report-2019.pdf.
Kinney, Eleanor D. “The International Human Right to Health: What Does This Mean for Our Nation and World?” Indiana Law Review 693, no. December (2004). https://mckinneylaw.iu.edu/ilr/pdf/vol34p1457.pdf.
Krcevski-Skvarc, N., C. Wells, and W. Häuser. “Availability and Approval of Cannabis-Based Medicines for Chronic Pain Management and Palliative/Supportive Care in Europe: A Survey of the Status in the Chapters of the European Pain Federation.” European Journal of Pain (United Kingdom) 22, no. 3 (2018): 440–54. https://doi.org/10.1002/ejp.1147.
Kuret, Tadeja, Mateja Erdani Kreft, Rok Romih, and Peter Veranič. “Cannabidiol as a Promising Therapeutic Option in IC/BPS: In Vitro Evaluation of Its Protective Effects against Inflammation and Oxidative Stress.” International Journal of Molecular Sciences 24, no. 5 (2023). https://doi.org/10.3390/ijms24055055.
Lee, Jimmy, Christopher Cheok, Gomathinayagam Kandasami, Attilio Rapisarda, and Ho New Fei. “A Literature Review on Medical Cannabis.” Singapore, 2015. https://www.mha.gov.sg/docs/default-source/media-room-doc/a-literature-review-on-medical-cannabis.pdf.
Malik, Syamsul, Luriana Manalu, and Rika Juniarti. “Legalisasi Ganja Dalam Sektor Medis Perspektif Hukum.” Jurnal Rechten : Riset Hukum Dan Hak Asasi Manusia 2, no. 2 (2022): 1–9. https://doi.org/10.52005/rechten.v2i2.52.
Marisca Evalina Gondokesumo, and Nabbilah Amir. “Legality of Marijuana Use in the Need for Medical Treatment in Indonesia (Judging From Law Number 36 of 2009 Concerning Health and Law Number 35 of 2009 Concerning Narcotics).” Journal Equity of Law and Governance 1, no. 2 (2021): 119–26. https://doi.org/10.55637/elg.1.2.3938.119-126.
Mead, Alice. “Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.” Frontiers in Plant Science 10, no. June (2019): 1–10. https://doi.org/10.3389/fpls.2019.00697.
Monalisa, Monalisa, Sri Rahayu, and Dheny Wahyudhi. “A Comparative Study on Criminal Sanction Against Drugs Offenders.” Jambe Law Journal 2, no. 2 (2020): 181–206. https://doi.org/10.22437/jlj.2.2.181-206.
MTP Connect & Deloitte Access Economics. “Australian Medicinal Cannabis Industry Report.” Victoria, Australia, 2021. https://www.mtpconnect.org.au/images/MTPC_Australian Medicinal Cannabis Industry.pdf.
National Center for Biotechnology Information. PubChem Compound Summary for CID 16078, Dronabinol (Maryland, US: National Center for Biotechnology Information, 2023). https://pubchem.ncbi.nlm.nih.gov/compound/Dronabinol.
Nik Mohamed, Mohamad Haniki, Nor Ilyani Mohamed Nazar, Irna Elina Ridzwan, Nor Hidayah Mohd Taufek, and Norny Syafinaz Ab Rahman. “Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements.” Journal of the Malaysian Parliament 2 (2022): 248–73. https://doi.org/10.54313/journalmp.v2i.66.
Nur Arfiani, and Indah Woro Utami. “Penggunaan Ganja Medis Dalam Pengobatan Rasional Dan Pengaturannya Di Indonesia.” Jurnal Hukum Dan Etika Kesehatan 2 (2022): 56–68. https://doi.org/10.30649/jhek.v2i1.45.
Perucca, Emilio. “Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?” Journal of Epilepsy Research 7, no. 2 (2017): 61–76. https://doi.org/10.14581/jer.17012.
Pitri Susanti, Ni. “Identifikasi Kandungan Cannabinoid dalam Ekstrak Batang Ganja Dengan Metode AL-TLC dan HPTLC Spectrophotodensitometry.” Indonesian Journal of Legal and Forensic Sciences 2, no. 1 (2012): 282193.
Pramana, Edy. “Lebih Dari Separo Warga Singapura Setuju Gunakan Ganja Untuk Medis.” JawaPos.com, 2022. https://www.jawapos.com/internasional/01411411/lebih-dari-separo-warga-singapura-setuju-gunakan-ganja-untuk-medis.
Prassetyo, Erik Dwi. “Legalisasi Ganja Medis (Analisis Putusan MK Nomor 106/PUU-XVIII/2020).” Jurnal Analisis Hukum 5, no. 2 (2022): 147–62. https://doi.org/10.38043/jah.v5i2.3735.
Pratama, Akbar Yudha, Ufran Ufran, and Lalu Saepuddin. “Studi Komparasi Antara Indonesia Dengan Thailand Terkait Kebijakan Legislasi Ganja.” Parhesia 1, no. 1 (2023): 70–81. https://journal.unram.ac.id/index.php/Parhesia/article/view/2578/1324.
Irianto, Agus, et.al. Survei Penyalahgunaan Narkoba Tahun 2021. (Jakarta: Pusat Penelitian, Data, dan Informasi Badan Narkotika Nasional Republik Indonesia, 2022). Available online at < https://ppid.bnn.go.id/konten/unggahan/2020/10/SURVEI-NASIONAL-PENYALAHGUNAAN-NARKOBA-TAHUN-2021.pdf>
Qadrina, Nurlaelatil, and M. Chaerul Risal. “Legalisasi Ganja Sebagai Tanaman Obat: Perlukah?” Jurnal Al Tasyri’Iyyah 2, no. 1 (2022): 48–58. https://doi.org/10.24252/jat.vi.30201.
Setiawan, Riyan. “Uji Materi UU Narkotika: Perjuangan Seorang Ibu Menuntut Legalisasi Ganja Medis Demi Anaknya.” Tirto.id, 2022. https://tirto.id/perjuangan-seorang-ibu-menuntut-legalisasi-ganja-medis-demi-anaknya-gtsY.
Souza, Maíra Ribeiro de, Amélia Teresinha Henriques, and Renata Pereira Limberger. “Medical Cannabis Regulation: An Overview of Models around the World with Emphasis on the Brazilian Scenario.” Journal of Cannabis Research 4, no. 1 (2022). https://doi.org/10.1186/s42238-022-00142-z.
Stockings, Emily, Dino Zagic, Gabrielle Campbell, Megan Weier, Wayne D. Hall, Suzanne Nielsen, Geoffrey K. Herkes, Michael Farrell, and Louisa Degenhardt. “Evidence for Cannabis and Cannabinoids for Epilepsy: A Systematic Review of Controlled and Observational Evidence.” Journal of Neurology, Neurosurgery and Psychiatry 89, no. 7 (2018): 741–53. https://doi.org/10.1136/jnnp-2017-317168.
Subramaniam, Chandra Segaran. “Drug Laws in Malaysia: Whether the Drug Laws Have Been Effective in Curbing the Drug Menace in Malaysia.” Resource Material Series No. 106, 2018. https://www.unafei.or.jp/publications/pdf/RS_No106/No106_10_IP_Malaysia.pdf.
The European Parliament. “Use of Cannabis for Medicinal Purposes,” no. February 2019 (2020): 115–18.
Undang-Undang Nomor 39 Tahun 1999 tentang Hak Asasi Manusia, Pub. L. No. 39 (1999). https://www.dpr.go.id/dokjdih/document/uu/440.pdf.
Undang-Undang Republik Indonesia Nomor 17 Tahun 2023 Tentang Kesehatan, Undang-Undang § (2023). https://www.kemkes.go.id/id/undang-undang-republik-indonesia-nomor-17-tahun-2023-tentang-kesehatan.
UNODC. "Herbal Cannabis for Medical Use: A Spectrum of Regulatory Approaches". Word Drug Report 2023 (2023). https://doi.org/10.18356/9789210028233c024.
Victor, Brenda, Kathy Hager, and Shannon Stacy. “Re-Legalizing Cannabis for Medical Use in the USA.” Journal of Public Health (United Kingdom) 44, no. 3 (2022): 679–84. https://doi.org/10.1093/pubmed/fdab066.
WHO. “WHO Endorses Decisions of Expert Committee on Cannabis and Other Substances.” WHO News Online (2019). https://www.who.int/news/item/03-04-2019-WHO-endorses-decisions-Expert-Committee-on-cannabis-and-other-substances.
WHO. “WHO Expert Committee on Drug Dependence Meets to Review Cannabis and Other Substances.” World Health Organization, 2018. https://www.who.int/news/item/16-11-2018-Expert-Committee-on-Drug-Dependence-meets-to-review-cannabis-and-other-substances.
Yamin, Alicia Ely. “The Right to Health under International Law and Its Relevance to the United States.” American Journal of Public Health 95, no. 7 (2005): 1156–61. https://doi.org/10.2105/AJPH.2004.055111.
Zinboonyahgoon, Nantthasorn, Sahaphume Srisuma, Wirun Limsawart, Andrew S.C. Rice, and Chuthamanee Suthisisang. “Medicinal Cannabis in Thailand: 1-Year Experience after Legalization.” Pain 162, no. 7 (2021): S105–9. https://doi.org/10.1097/j.pain.0000000000001936.
Zulfikri, Agung, and Ujang Badru Jaman. “Urgensi Legalitas Ganja Untuk Kepentingan Medis.” Jurnal Hukum dan HAM West Science 01, no. 1 (2022): 8–14.